반복 풍선 이관 튜브 확장술의 임상적 분석
Clinical Analysis of Repeat Balloon Eustachian Tube Dilatation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives Obstructive Eustachian tube dysfunction (OETD) is a com-plex condition in which middle ear ventilation control is impaired. OETD is often not im-proved by medication nor by nasal washing or nasal spray. On the other hand, balloon Eusta-chian tube dilatation (BETD) is an effective surgery in OETD although repeating BETD iscontroversial as it involves additional procedure such as ventilation tube, middle ear steroidirrigation, and trans-tympanic Eustachian tube probing in some cases. This study aims to ana-lyze the clinical differences between patients who received single BETD and repeat BETD,and to evaluate the efficacy of repeat BETD. Subjects and Method For the study, 110 single groups, and 16 repeat groups were selectedfrom patients who underwent BETD from Nov 2019 to Aug 2022. Age, gender, underlyingdiseases, history of rhinitis and smoking, and Eustachian Tube Dysfunction Questionnaire-7(ETDQ-7) were analyzed for the selected groups. Results There were no significant differences in gender, underlying disease, or history of rhi-nitis between the two groups. However, age was significantly younger in the repeat group (45.91vs. 33.38, p=0.006), while smoking (5.64 vs. 1.66, p=0.01) was significantly higher in the singlegroup. The rate of improvement in the ETDQ-7 was 81.3% in the single group and 69.2% inboth initial and repeated surgeries in the repeat group. The complete remission rate was 60% inthe single group, and 38.5% in both initial and repeated surgeries of the repeat group. Conclusion For patients who are unsatisfied with the first surgery, it is meaningful enoughto recommend repeat BETD, for which additional procedures are performed simultaneously.
Abstract
Background and Objectives Obstructive Eustachian tube dysfunction (OETD) is a com-plex condition in which middle ear ventilation control is impaired. OETD is often not im-proved by medication nor by nasal washing or nasal spray. On the other hand, balloon Eusta-chian tube dilatation (BETD) is an effective surgery in OETD although repeating BETD iscontroversial as it involves additional procedure such as ventilation tube, middle ear steroidirrigation, and trans-tympanic Eustachian tube probing in some cases. This study aims to ana-lyze the clinical differences between patients who received single BETD and repeat BETD,and to evaluate the efficacy of repeat BETD. Subjects and Method For the study, 110 single groups, and 16 repeat groups were selectedfrom patients who underwent BETD from Nov 2019 to Aug 2022. Age, gender, underlyingdiseases, history of rhinitis and smoking, and Eustachian Tube Dysfunction Questionnaire-7(ETDQ-7) were analyzed for the selected groups. Results There were no significant differences in gender, underlying disease, or history of rhi-nitis between the two groups. However, age was significantly younger in the repeat group (45.91vs. 33.38, p=0.006), while smoking (5.64 vs. 1.66, p=0.01) was significantly higher in the singlegroup. The rate of improvement in the ETDQ-7 was 81.3% in the single group and 69.2% inboth initial and repeated surgeries in the repeat group. The complete remission rate was 60% inthe single group, and 38.5% in both initial and repeated surgeries of the repeat group. Conclusion For patients who are unsatisfied with the first surgery, it is meaningful enoughto recommend repeat BETD, for which additional procedures are performed simultaneously.
참고문헌 (17)
- McMurran AEL, "Balloon eustachian tuboplasty for eustachian tube dysfunction : Report of long-term outcomes in a UK population", J Laryngol Otol, 134(1), pp.34~40 (2020)
- Metson R, "Microdebrider eustachian tuboplasty : A preliminary report", Otolaryngol Head Neck Surg, 136(3), pp.422~427 (2007)
- Caffier PP, "Impact of laser eustachian tuboplasty on middle ear ventilation, hearing, and tinnitus in chronic tube dysfunction", Ear Hear, 32(1), pp.132~139 (2011)
- Seibert JW, "Eustachian tube function and the middle ear", Otolaryngol Clin North Am, 39(6), pp.1221~1235 (2006)
- Ockermann T, "Balloon dilation eustachian tuboplasty : A feasibility study", Otol Neurotol, 31(7), pp.1100~1103 (2010)
- McCoul ED, "Eustachian tube balloon dilation surgery", Int Forum Allergy Rhinol, 2(3), pp.191~198 (2012)
- Silvola J, "Balloon dilation of the cartilaginous portion of the eustachian tube", Otolaryngol Head Neck Surg, 151(1), pp.125~130 (2014)
- Poe D, "Balloon dilation of the eustachian tube for dilatory dysfunction : A randomized controlled trial", Laryngoscope, 128(5), pp.1200~1206 (2018)
- Meyer TA, "A randomized controlled trial of balloon dilation as a treatment for persistent eustachian tube dysfunction with 1-year follow-up", Otol Neurotol, 39(7), pp.894~902 (2018)
- Xiong H, "Efficacy of balloon dilation in the treatment of symptomatic eustachian tube dysfunction : One year follow-up study", Am J Otolaryngol, 37(2), pp.99~102 (2016)
- Cutler JL, "Long-term outcomes of balloon dilation for persistent eustachian tube dysfunction", Otol Neurotol, 40(10), pp.1322~1325 (2019)
- Cheng H, "Balloon dilation eustachian tuboplasty for dilatory dysfunction : Safety and efficacy analysis in an Australian cohort", ANZ J Surg, 91(7-8), pp.1480~1484 (2021)
- Keschner D, "Repeat eustachian tube balloon dilation outcomes in adults with chronic eustachian tube dysfunction", Otolaryngol Head Neck Surg, 166(5), pp.951~956 (2022)
- McCoul ED, "Validating the clinical assessment of eustachian tube dysfunction : The eustachian tube dysfunction questionnaire(ETDQ-7)", Laryngoscope, 122(5), pp.1137~1141 (2012)
- Teixeira MS, "Accuracy of the ETDQ-7 for identifying persons with eustachian tube dysfunction", Otolaryngol Head Neck Surg, 158(1), pp.83~89 (2018)
- Tangbumrungtham N, "The prevalence of eustachian tube dysfunction symptoms in patients with chronic rhinosinusitis", Int Forum Allergy Rhinol, 8(5), pp.620~623 (2018)
- 2021 national health and nutrition survey, "Korea Disease Control and Prevention Agency", Korea Disease Control and Prevention Agency, ~ (2021)
